Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-17

Clinical Trial Update: Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

View source ↗

Summary

A real-world observational study evaluating naloxegol for opioid-induced constipation in cancer pain patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxegol (naloxegol)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Opioid Induced Constipation | Status: COMPLETED